Reuters logo
BRIEF-Soleno Therapeutics CFO David O’Toole to transition from Soleno in mid-Sept ‍​
September 5, 2017 / 9:08 PM / 14 days ago

BRIEF-Soleno Therapeutics CFO David O’Toole to transition from Soleno in mid-Sept ‍​

Sept 6 (Reuters) - Soleno Therapeutics Inc

* Soleno Therapeutics Inc says David O’Toole, company’s chief financial officer, will transition from Soleno in mid-September - SEC filing ‍​

* Says Jonathan R. Wolter appointed interim CFO Source text: (bit.ly/2x898M3) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below